L&C BIO Co Ltd Ordinary Shares 290650
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 21,100.00
- Day Range
- KRW 20,600.00–21,150.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 20,700.00 / KRW 20,800.00
- Market Cap
- KRW 466.60 Bil
- Volume/Avg
- 80,698 / 109,211
Key Statistics
- Price/Earnings (Normalized)
- 80.42
- Price/Sales
- 6.95
- Dividend Yield (Trailing)
- 0.47%
- Dividend Yield (Forward)
- 0.47%
- Total Yield
- 0.65%
Company Profile
L&C BIO Co Ltd manufactures and distributes medical equipment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 117
- Website
- http://www.lncbio.co.kr
Comparables
Valuation
Metric
|
290650
|
214150
|
150840
|
---|---|---|---|
Price/Earnings (Normalized) | 80.42 | 32.86 | — |
Price/Book Value | 3.26 | 8.54 | 4.48 |
Price/Sales | 6.95 | 13.46 | 26.93 |
Price/Cash Flow | 33.39 | 33.14 | — |
Price/Earnings
290650
214150
150840
Financial Strength
Metric
|
290650
|
214150
|
150840
|
---|---|---|---|
Quick Ratio | 0.80 | 5.33 | 0.49 |
Current Ratio | 1.28 | 6.35 | 0.98 |
Interest Coverage | 10.92 | 46.55 | −1.43 |
Quick Ratio
290650
214150
150840
Profitability
Metric
|
290650
|
214150
|
150840
|
---|---|---|---|
Return on Assets (Normalized) | 21.54% | 21.05% | −28.93% |
Return on Equity (Normalized) | 42.03% | 29.26% | −63.47% |
Return on Invested Capital (Normalized) | 25.04% | 22.51% | −23.99% |
Return on Assets
290650
214150
150840
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Fkkgxwjr | Fbljcs | $184.3 Bil | |
SYK
| Stryker Corp | Fpjrhspw | Zxth | $125.0 Bil | |
MDT
| Medtronic PLC | Qvvfxhjvl | Zdwbq | $107.4 Bil | |
BSX
| Boston Scientific Corp | Gkqktdtj | Fdrmzl | $106.2 Bil | |
EW
| Edwards Lifesciences Corp | Gzzwhgqbch | Shccgc | $50.8 Bil | |
DXCM
| DexCom Inc | Pqcpdjjfgb | Gxzf | $50.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jghccyxgjb | Cdtp | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Typpxdf | Zbkkwx | $24.5 Bil | |
ALGN
| Align Technology Inc | Jndndlsx | Qqgml | $21.4 Bil | |
PODD
| Insulet Corp | Xxyhyfftv | Jktlmy | $12.1 Bil |